Determination of Interleukin-6 (IL-6) in Cerebrospinal Fluid: Potential Role for the Evaluation of the Vital Prognosis in Bacterial Meningitis

Background: To analyze whether the determination of interleukin-6 levels in cerebrospinal fluid is useful as a biomarker for the severity of bacterial meningitis. Methodology: Cerebrospinal fluid was obtained from 120 patients aged 0-15 years with meningitis. They were classified as having bacterial meningitis (n = 85) or aseptic meningitis (n = 35) according to the cerebrospinal fluid white blood cell count, microbiological culture and molecular methods. Interleukin-6 levels were determined by enzyme-linked immunosorbent assay. Results: No significant change in the mean interleukin-6 level on the basis of clinical signs was observed in patients with bacterial meningitis. However, the cerebrospinal fluid total protein level was elevated in patients with alertness problems (3.41±2.26 g LG1). There was a significant correlation (Pearson correlation p#0.05) between the cerebrospinal fluid glucose and total protein levels in patients with bacterial meningitis. The mean cerebrospinal fluid interleukin-6 level (4,472.0±2,494.52 pg mLG1) in patients with bacterial meningitis whose disease outcome was fatal was significantly higher (p#0.05) than that of those who survived the disease (2,983.28±2,612.13 pg mLG1). Conclusion: Interleukin-6 is a potential biomarker for identifying bacterial meningitis patients with a high risk of death who require intensive care.

[1]  E. Martínez-Morillo,et al.  Interleukin-6 in cerebrospinal fluid as a biomarker of acute meningitis , 2016, Annals of clinical biochemistry.

[2]  Yu Cao,et al.  Diagnostic performance of interleukin-6 and interleukin-8 for bacterial meningitis: a meta-analysis. , 2015, International journal of clinical and experimental medicine.

[3]  Kumiko Tanaka,et al.  Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis. , 2014, Journal of critical care.

[4]  K. Iserson,et al.  Acute meningitis prognosis using cerebrospinal fluid interleukin-6 levels. , 2012, The Journal of emergency medicine.

[5]  Ruchi Srivastava,et al.  A study of cytokines in tuberculous meningitis: Clinical and MRI correlation , 2010, Neuroscience Letters.

[6]  L. Ananthanarayan,et al.  Glucose oxidase--an overview. , 2009, Biotechnology advances.

[7]  Jen-Her Lu,et al.  Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis , 2009, Child's Nervous System.

[8]  H. Lei,et al.  Cerebrospinal fluid cytokines in enterovirus 71 brain stem encephalitis and echovirus meningitis infections of varying severity. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  S. Chanteau,et al.  Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  S. Kaplan,et al.  Practice guidelines for the management of bacterial meningitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Dean A Seehusen,et al.  Cerebrospinal fluid analysis. , 2003, American family physician.

[12]  H. Pfister,et al.  Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. , 2002, The Journal of infectious diseases.

[13]  H. Pfister,et al.  Pathogenesis and pathophysiology of pneumococcal meningitis. , 2002, The Lancet. Infectious diseases.

[14]  T. Wong,et al.  Interleukin-1β and tumor necrosis factor-α in cerebrospinal fluid of children with bacterial meningitis , 2001, Child's Nervous System.

[15]  M. Taha,et al.  Simultaneous Approach for Nonculture PCR-Based Identification and Serogroup Prediction of Neisseria meningitidis , 2000, Journal of Clinical Microbiology.

[16]  D. Gruol,et al.  Physiological and pathological roles of interleukin-6 in the central nervous system , 1997, Molecular Neurobiology.

[17]  A. Cross,et al.  Blood–Brain Barrier Permeability during the Development of Experimental Bacterial Meningitis in the Rat , 1997, Experimental Neurology.

[18]  L. Mccawley,et al.  Cytokine elevations in infants with bacterial and aseptic meningitis. , 1995, The Journal of pediatrics.

[19]  A. Tunkel,et al.  Pathogenesis and pathophysiology of bacterial meningitis , 1993, Clinical Microbiology Reviews.

[20]  O. Casasnovas,et al.  High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis. , 1992, The Journal of infectious diseases.

[21]  The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis , 1992 .

[22]  S. Baron,et al.  Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review. , 1991, Reviews of infectious diseases.

[23]  C. Speicher.  Effects of Disease on Clinical Laboratory Tests , 1990 .

[24]  A. Tunkel,et al.  Bacterial meningitis: recent advances in pathophysiology and treatment. , 1990, Annals of internal medicine.

[25]  P. Lustenberger,et al.  An improved pyrogallol red-molybdate method for determining total urinary protein. , 1989, Clinical chemistry.

[26]  O. P. Mishra,et al.  Cerebrospinal fluid TNF-α, IL-6, and IL-8 in children with bacterial meningitis. , 2014, Pediatric neurology.

[27]  L. Kępa,et al.  Cerebrospinal fluid interleukin-6 concentration in patients with purulent, bacterial meningitis - own observations. , 2014, Przeglad epidemiologiczny.

[28]  A. Turner,et al.  Glucose oxidase: an ideal enzyme , 1992 .

[29]  D. Chan,et al.  Immunoassay : a practical guide , 1987 .